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Background: Diabetes mellitus is a chronic metabolic disorder that results in abnormal blood glucose (BG) regulations. The
BG level is preferably maintained close to normality through self-management practices, which involves actively tracking BG
levels and taking proper actions including adjusting diet and insulin medications. BG anomalies could be defined as any undesirable
reading because of either a precisely known reason (normal cause variation) or an unknown reason (special cause variation) to
the patient. Recently, machine-learning applications have been widely introduced within diabetes research in general and BG
anomaly detection in particular. However, irrespective of their expanding and increasing popularity, there is a lack of up-to-date
reviews that materialize the current trends in modeling options and strategies for BG anomaly classification and detection in
people with diabetes.
Objective: This review aimed to identify, assess, and analyze the state-of-the-art machine-learning strategies and their hybrid
systems focusing on BG anomaly classification and detection including glycemic variability (GV), hyperglycemia, and hypoglycemia
in type 1 diabetes within the context of personalized decision support systems and BG alarm events applications, which are
important constituents for optimal diabetes self-management.
Methods: A rigorous literature search was conducted between September 1 and October 1, 2017, and October 15 and November
5, 2018, through various Web-based databases. Peer-reviewed journals and articles were considered. Information from the selected
literature was extracted based on predefined categories, which were based on previous research and further elaborated through
brainstorming.
Results: The initial results were vetted using the title, abstract, and keywords and retrieved 496 papers. After a thorough
assessment and screening, 47 articles remained, which were critically analyzed. The interrater agreement was measured using a
Cohen kappa test, and disagreements were resolved through discussion. The state-of-the-art classes of machine learning have
been developed and tested up to the task and achieved promising performance including artificial neural network, support vector
machine, decision tree, genetic algorithm, Gaussian process regression, Bayesian neural network, deep belief network, and others.
Conclusions: Despite the complexity of BG dynamics, there are many attempts to capture hypoglycemia and hyperglycemia
incidences and the extent of an individual’s GV using different approaches. Recently, the advancement of diabetes technologies
and continuous accumulation of self-collected health data have paved the way for popularity of machine learning in these tasks.
According to the review, most of the identified studies used a theoretical threshold, which suffers from inter- and intrapatient
variation. Therefore, future studies should consider the difference among patients and also track its temporal change over time.
Moreover, studies should also give more emphasis on the types of inputs used and their associated time lag. Generally, we foresee
that these developments might encourage researchers to further develop and test these systems on a large-scale basis.
J Med Internet Res 2019 | vol. 21 | iss. 5 | e11030 | p.1https://www.jmir.org/2019/5/e11030/
(page number not for citation purposes)
Woldaregay et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
(J Med Internet Res 2019;21(5):e11030)   doi:10.2196/11030
KEYWORDS
type 1 diabetes; blood glucose dynamics; anomalies detection; machine learning
Introduction
Background
Diabetes mellitus is a chronic metabolic disorder that results in
abnormal blood glucose (BG) regulation. The BG level is
maintained close to normality through self-management
practices, which involves actively tracking BG levels and taking
proper actions including diet and insulin medications. The
estimated number of people with diabetes aged between 20 and
79 years was 415 million (uncertainty interval: 340-536 million)
in 2015 and is expected to reach 642 million (uncertainty
interval: 521-829 million) by 2040 [1]. The global economic
burden of diabetes in adults aged between 20 and 79 years was
estimated to be US $1.31 trillion (95% CI 1.28-1.36) in 2015
[2]. The total number of deaths attributed to diabetes is estimated
to be 5 million in people with diabetes aged between 20 and 79
years [1]. People with diabetes have a higher risk of getting
infections as compared with the normal population, which
potentially increases their morbidity and mortality [3]. The
greater and frequent risk of infections is mainly correlated with
a hyperglycemia environment [3,4]. Moreover, studies suggest
a hypoglycemia episode could result in a higher hospitalization
and mortality rate [5].
The individual’s BG dynamic is affected by various factors,
which are mainly categorized as common, individual, and
unpredictable factors [6]. The common factors include amount
of food intake, insulin intake, previous level of BG, pregnancy,
drug and vitamin intake, smoking, and alcohol intake. The
individual factors include dawn phenomena, physical exercise
load, and menstruation. The unpredictable factors include stress,
concomitant diseases, and infections [6]. Swings in BG
dynamics, that is, hypoglycemia and hyperglycemia, could be
generally categorized under a normal cause variation and special
cause variation. The normal cause variation is regarded as caused
by those common and individual factors, whereas the special
cause variation is caused by those unpredictable factors. The
underlying reason of the special cause variations is difficult to
understand and remains a challenge for the patient during the
incidences. For instance, during stress and infections, the patient
usually struggles with hyperglycemia and injects frequent insulin
to lower his or her BG levels.
BG anomalies could be defined as any undesirable reading
because of either a precisely known reason (normal cause
variation) or an unknown reason (special cause variation) to the
patient [7]. Even if the advancement in self-management
applications and diabetes monitoring technologies has made
things easier, the challenge of BG anomalies remains to be
managed by the patient themselves. There are some
technological developments in the direction of personalized
decision systems and BG event alarms to provide an alert and
decision support to the patient in the time of these challenges.
Techniques such as classification and detection of glycemic
variability (GV), hypoglycemia, and hyperglycemia, in
particular, and BG anomalies, in general, are central to the
development of these diabetes technologies. The ubiquitous
nature and widespread use of mobile health (mHealth) apps,
sensors and wearables, and other point-of-care (POC) devices
for self-monitoring and management purposes have made
possible the generation of automated and continuous
diabetes-related data, which brought an opportunity for the
introduction of machine learning and its application for
intelligent and improved systems, which is capable of solving
complex tasks within a dynamic knowledge and dynamic
environment. In this regard, there are some reviews conducted
toward the applications of artificial intelligence in
diabetes-related tasks. For instance, Contreras et al [8] conducted
literature reviews on the applications of artificial intelligence
in the context of critical diabetes management issues such as
BG prediction and strategies for BG control, adverse glycemic
events detection, bolus calculators and advisory system, patient
personalization (tailored features), and others [8]. Moreover,
Rigla et al [9] also conducted a review to provide a general
overview and popularity of artificial intelligence applications
to diabetes problems. Generally, both Contreras et al [8] and
Rigla et al [9] tried to demonstrate the potential of artificial
intelligence with regard to all groups of people with diabetes
focusing on general self-management issues. As far as our
knowledge is concerned, there are almost no reviews conducted
toward techniques of BG anomaly classification and detection
focusing on various approaches, in general, and
machine-learning applications, in particular. However, there
were some reviews conducted to evaluate the significant effect
of pattern management based on self-monitoring BG (SMBG)
with regard to clinical practices [10]. Therefore, we suggest that
there is a lack of reviews focusing on BG anomaly classification
and detection. The objective of this review was to identify,
assess, and analyze the state-of-the-art machine-learning
strategies in BG anomaly classification and detection including
GV, hyperglycemia, and hypoglycemia in people with type 1
diabetes. Moreover, it has presented the current modeling
options of machine-learning applications and their hybrid
systems. The review covers machine-learning approaches
pertinent to personalized decision support systems and BG alarm
events applications in type 1 diabetes.
Machine Learning Tasks in Type 1 Diabetes
Machine-learning approaches (tasks) are generally categorized
as regression, prediction, classification, detection, and clustering,
which are grouped either in supervised, semisupervised,
unsupervised, or reinforcement learning based on the type of
learning employed. Generally, reinforcement learning is out of
the scope of this review, where we mainly focus on the other 3
categories. Machine learning–based data mining tasks could be
categorized as descriptive or unsupervised (ie, clustering,
association, and summarization), semisupervised (ie,
classification and detection), and predictive or supervised
learning (ie, classification and regression) [11]. In this regard,
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the most widely used machine learning–based data mining tasks
in the literature are BG anomalies detection, BG prediction,
modeling of BG dynamics, and decision making or education,
as shown in Figure 1. In this review, we will focus on the typical
applications of classification and detection tasks in diabetes
research, specifically in BG anomaly detection within the context
of a personalized decision support system and BG alarm events
applications. The review considers various classes of machine
learning algorithms: artificial neural network (ANN), decision
trees (DTs), support vector machine (SVM), evolutionary
algorithms (EAs), and others.
An ANN is a biologically inspired computational model
consisting of a set of interconnected neurons and a scaled
connection between them that is called weights [12]. On the
basis of network topology, an ANN is mainly categorized as a
feedforward ANN (single-layer perceptron (SLP), multi-layer
perceptron (MLP), and radial basis function [RBF]) and
feedback ANN (recurrent neural network [RNN], Elman net,
Kohonen’s self-organizing map (SOM), and Hopfield networks)
[12]. The SVM works based on the theory of structural risk
minimization principle [13]. Learning in the SVM occurs
through finding an optimal hyperplane that can maximize the
margin between the classes. The SVM has been widely exploited
in numerous applications such as regression and prediction,
pattern identification and recognition, categorization, and
classification [13]. An EA is a biologically inspired approach
to problem solving [14]. The 2 most used variants of EA are
genetic programming (GP) and genetic algorithm (GA). Random
forest (RF) or DTs are a kind of an ensemble approach of
learning for different classification and regression applications,
which mainly learns by constructing a multitude of DTs
generating the mode of the class or mean of prediction. The
hidden Markov model (HMM) is a variant of the statistical
Markov model, where the system being modeled is assumed to
follow a Markov property with unobserved states [15]. There
are various versions of HMMs; however, in this review, we
considered only those trained with a framework close to machine
learning families. Hybridization is the process of combining 2
or more different approaches in parallel or serious connection,
either at the preprocessing stage, feature extraction, or learning
stage, when looking for an improved performance [16].
Figure 1. Most widely used machine learning–based data mining tasks based on self-recorded data in people with type 1 diabetes. The yellow shaded
ellipse depicts the scope of this review.
Blood Glucose Anomaly Classification and Detection
Hawkins defined anomalies as “observations that deviate much
from the other observations so as to arouse suspicions that it
could be generated by a different process” [7,17,18]. There are
terms that are often used interchangeably with anomalies, such
as outliers, deviations, exceptions, rare instances, and
irregularities. The problem of identifying and capturing
anomalies in data can be supervised, semisupervised, and
unsupervised tasks [19,20]. These strategies can roughly be
categorized as classifier- or model-based (detection) approach.
The semisupervised is better when anomalous instances are not
easily available, whereas supervised techniques are more suitable
when there are sufficient labeled instances of both normal and
anomalous instances. The unsupervised approach does not
require any reference data labels, where normal behaviors have
to be determined dynamically, and the detections are mainly
performed with regard to the entire datasets. The model-based
strategies can be considered as a diagnosis of the system’s
behavior during abnormal situations through modeling and
adequately characterizing the system’s behavior during normal
situations [19,21]. It uses a system’s model to either estimate
or predict the underlying system (process) dynamics to capture
anomalies in the data. The most important design requirement
in using a model includes discovering and characterizing what
is to be considered a normal pattern of behaviors [22]. Unlike
the classifier-based strategies, the model-based strategies do
not require rigorous knowledge of the underlying expected
anomalies, that is, to fully understand and characterize the shape
and nature of the expected anomalies [22]. By simply defining
what is the expected normal pattern the system should exhibit,
the model-based anomaly detection is capable of detecting
abnormal behavior, which is not considered as the normal
behavior of the system. Defining and discovering what is normal
is a challenging task especially for dynamic and complex
systems, for example, BG dynamics. However, this is often
tackled in a dynamic and complex system by relying on either
a machine learning model trained on a large enough dataset or
using an explicit mathematical model, for example,
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physiological model of BG dynamics, of the system if it exists
already.
BG readings are time series data, and anomalies in BG levels
could be regarded as any undesirable readings, as shown in
Figure 1, because of either a predictable cause (normal cause
variation) or an unpredictable cause (special cause variation).
A normal cause variation could be defined as any hypoglycemia
or hyperglycemia incidences with the underlying cause known
to the patient herself or himself and also referred as predictable
(patient controllable) factors such as insulin injection, diet
intake, physical activity, and others. However, special cause
variation refers to any hypoglycemia or hyperglycemia
incidences with the underlying cause unknown to the patient
and also called unpredictable (patient uncontrollable) factors
such as stress, infections, insulin set failure, and others. The
classifier, semisupervised (model)– and unsupervised-based
approach could be used to solve the challenge of capturing BG
anomalies caused by both the predictable factors (normal cause
variation) and unpredictable cause (special cause variation).
However, regarding the unpredictable factors (special cause
variation), the classifier-based approach remains to be very
challenging with limited feasibility as the classifier-based
strategies require a thorough understanding and characterization
of the nature, size, and shape of the anomalies, along with its
inter- and intravariability among the patients. With the same
token, the unsupervised approach could face the same challenge
as it does not have any mechanisms for differentiating the one
with special cause from the normal cause variations. However,
the model-based (semisupervised) approach happens to be more
appropriate given that it only requires to characterize what is
considered to be normal so as to detect what is believed to be
abnormal. For example, infection (stress)–related hyperglycemia
and a diet-induced hyperglycemia are treated differently
according to the model-based (semisupervised) anomaly
detection strategies. In this regard, diet-induced hyperglycemia
is treated as normal, as the model could describe the underlying
cause (certain meal), but infection-related hyperglycemia is
considered as an anomaly because the model cannot describe
the underlying cause based on patient controllable variables (eg,
meals and insulin).
GV measures the degree or the rate at which the patient’s BG
fluctuates between high and low levels [23]. GV is useful to
provide all-inclusive information on one’s self-management
practices concerning postprandial spikes in BG, as well as
episodes of hypoglycemic and hyperglycemic events [23,24],
which are the main factors that contribute for a higher risk of
cardiovascular events in people with diabetes. The evaluation
of GV helps to comprehend and assess the effect of the patient’s
timely actions on the hypoglycemia and hyperglycemia
incidence by associating out-of-target BG levels with
patient-specific factors, such as insulin dosage, other medication,
meals, activity, stress, and illness [23]. However, there is no
gold standard approach for assessing GV, and despite its
importance, it remains to be challenging.
Blood Glucose Prediction
BG prediction is about forecasting an individual’s future BG
levels using current and past information and is also an important
constituent of BG anomaly classification and detection
approaches. It mainly aims to provide crucial alarms for patients
in advance with sufficient lead time so as to avoid further
complications from hypoglycemia or hyperglycemia incidences.
According to Oviedo et al [25], BG prediction models could be
categorized into 3 main groups: physiological models,
data-driven models, and hybrid models [25]. These categories
are solely demarcated based on the necessity of extensive
knowledge of the underlying BG dynamics: black box approach
(data-driven model), intermediate knowledge (hybrid model),
and extensive knowledge (physiological model). The data-driven
model, which is mainly referred to as black box model, uses the
patient’s continuous glucose monitoring (CGM), insulin, dietary,
and other relevant information to develop a prediction model,
for example, machine learning and time series approaches. There
are a variety of data-driven models developed and tested in the
literature including machine learning (neural network, support
vector regression, jump neural network, RNN, and others) and
time series models (autoregressive [AR] with exogenous input,
AR moving average with exogenous input, AR moving average,
and others) [25]. Hybrid models make use of the advantages
from the data-driven and physiological models [25]. Most of
the hybrid models rely on the physiological model to compute
meal and insulin information as input for the data-driven models
[25]. Physiological models mainly rely on 3 sets of mathematical
(differential) equations to describe the underlying dynamics:
BG dynamics, insulin dynamics, and meal absorption dynamics.
Physiological models are roughly grouped into lumped and
comprehensive models based on the way the model treats each
organ and tissue so as to develop the differential equations [26].
There are a variety of physiological models developed in the
literature such as Berger, Hovorka, Cobelli, Lehmann and
Deutsch model, and others [26]. Generally, there are plenty of
models implemented in the literature on the prediction of BG
levels [25,26]. However, BG prediction is not under the scope
of this review, and we mainly focus on the data-driven BG
pattern classification and anomaly detection approaches under
the umbrella of machine learning.
Methods
Search Strategy
The objective of this review was to identify, assess, and analyze
the state-of-the-art machine learning strategies and their hybrid
system focusing on BG anomaly classification and detection
including GV, hyperglycemia, and hypoglycemia in people with
type 1 diabetes. The review covers machine learning approaches
pertinent to personalized decision support systems and BG alarm
events applications. Therefore, for the purpose of the study, a
rigorous literature search was conducted between September 1
and October 1, 2017, through various Web-based databases
including Google scholar, IEEE Xplore, DBLP Computer
Science Bibliography, ScienceDirect, PubMed or Medline,
Journal of Diabetes Science and Technology, and Diabetes
Technology & Therapeutics. Additional search was also
conducted between October 15 and November 5, 2018, on those
databases to refine and update the records. Furthermore, the
reference list of the selected articles was used to extract
additional articles to get a complete overview of the field.
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Peer-reviewed journals and articles published between 2000
and 2018 were considered. The inclusion and exclusion criteria
were setup through rigorous discussion and brainstorming
among the authors. Different combinations of terms such as
diabetes, intelligent system, hybrid system, machine learning,
BG event indicators (hypo- and hyperglycemia prediction), BG
event alarm, BG personalized decision system, clinical,
closed-loop system, hyperglycemia, hypoglycemia, GV, and
personalized profile were used during the search. The terms
were combined using AND/OR for a better search strategy.
Relevant articles were first identified by reviewing the title,
keywords, and abstracts for a preliminary filter with our
selection criteria, and then we reviewed full text articles that
seemed relevant. Information from the selected literature was
extracted based on some predefined categories, which were
based on previous research, and further elaborated through
brainstorming.
Inclusion and Exclusion Criteria
To be included in the review, the studies should have developed,
implemented, tested, and discussed machine learning and any
of its hybrid approaches in type 1 diabetes focusing on one or
more of the following application areas:
• BG anomaly detection
• Hypoglycemia prediction, classification, or detection
• Hyperglycemia prediction, classification, or detection
• Glycemic or BG variability classification or detection
Therefore, the studies that reside outside of these stated scopes
were excluded from the review including all articles written in
other languages but English.
Data Categorization and Data Collection
Information was extracted from the selected studies based on
predefined parameters (variables) and categories. The categories
were defined based on rigorous brainstorming and discussion
among the authors. These categories were demarcated solely to
collect the relevant data and to assess, analyze, and evaluate the
model’s characteristics and its experimental setup.
Application Scenario
This category defines the type of applications where the machine
learning algorithm is being exploited. It can be hypoglycemia
and hyperglycemia prediction, classification and detection, or
GV classification and detection.
Type of Input
This category was defined to assess, analyze, and evaluate the
type of inputs used to develop the algorithm. This includes the
key diabetes parameters and other physiological parameters
relevant for BG anomaly classification and detections: BG, heart
rate variability, and others.
Data Format, Type, Size, and Data Source
This category was defined to assess, analyze, and evaluate the
type of data format used as input to the algorithm. This depends
on the basis of the type of diabetes technologies, mobile apps,
and POC devices used for data collection and algorithm
development. It includes different data formats such as from
CGM devices, mHealth apps (ie, diabetes diary), heart rate
monitoring devices, and others.
Input Preprocessing
This category defines the kind of preprocessing algorithm the
system implements so as to avoid missing, sparse, and corrupted
input data.
Class of Machine Learning
This category defines the class of machine learning algorithm
used to train and test the BG anomaly classification and
detection algorithm. It includes different classes of machine
learning algorithm: ANN, SVM, Bayesian network, DT, and
others.
Training or Learning Method and Algorithm
This category defines the class of learning algorithms used to
train the model. It includes different training algorithms such
as the backpropagation algorithm, kernel, optimization
techniques, and others.
Performance Metrics or Evaluation Criteria
This category defines the type of evaluation metrics used to
assess the accuracy of the classification and detection algorithm
implemented. It includes different performance metrics such as
specificity, sensitivity, receiver operating characteristic (ROC)
curves, and others.
Literature Evaluation
The included literature was analyzed and evaluated based on
the above defined categories and variables to uncover the
state-of-the-art machine learning applications in hyperglycemia
or hypoglycemia prediction, classification and detection, and
GV classification and detection. It also tries to pinpoint their
characteristics along with the experimental setup used to
implement and test the algorithms. The first evaluation and
analysis was carried out based on the type of input used to
develop the algorithms to uncover the state-of-the-art inputs
used in these circumstances. The second evaluation and analysis
was carried out based on the various classes of machine learning
used to develop these algorithms to uncover the rate of adoption
and their suitability to the task. The third evaluation and analysis
was carried out based on the performance metrics used to
evaluate the performance of these algorithms.
Results
Relevant Literature
The initial hit was vetted using the title, abstract, and keywords
and retrieved a total of 496 papers (DBLP Computer Science
(20), Diabetes Technology & Therapeutics (23), Google Scholar
(160), IEEE (215), Journal of Diabetes Science and Technology
(22), PubMed Medlin (27), and ScienceDirect (29); see Figure
2). After removing duplicates from the list, 410 records
remained. Then, we did an independent assessment of the
articles and screening based on the inclusion and exclusion
criteria, which eliminated another 215 papers, leaving 195
relevant papers. After a full-text assessment, 47 articles were
left (hyperglycemia=5, glycemic variabilities=3, and
hypoglycemia=39), which were critically analyzed as shown in
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Figures 2 and 3. The interrater agreement was measured using
a Cohen kappa test, and disagreements were resolved through
discussion.
Figure 2. Flow diagram of the review process.
Figure 3. The number of articles published per year of publication.
Evaluation and Analysis of the Literature
The literature, as described previously, was evaluated based on
the type of machine learning used to develop the algorithm, the
type of input used to train the system, and the performance
metrics used to evaluate the algorithm performance based on
the tables in Multimedia Appendices 1 and 2.
Data Characteristics and Input Parameters
Input Parameters
Selecting the proper types of input parameters is one of the
crucial design strategies for successful classification and
detection algorithm development. In this regard, the outer bigger
ring, the middle ring, and the inner ring in Multimedia Appendix
1 depict the types of input used in hypoglycemia, hyperglycemia,
and GV classification and detection algorithm, respectively.
According to hypoglycemia classification and detection
algorithm, BG, heart rate, and QT interval are the most used
types of input parameters (25/39, 64%). BG alone is the second
most used type of input parameter (4/39, 10%). BG and insulin
are the third most used types of input parameters along with
BG, insulin, diet, physical activity, and others (3/39, 8%). BG
and diet alone, along with BG, insulin, and diet, and BG, heart
rate, skin impedance, and BG, insulin, diet, heart rate, galvanic
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response, skin impedance are the fifth most used types of input
parameters (1/39, 3%). According to hyperglycemia
classification and detection algorithm, BG alone, and BG and
insulin represent the most used types of input parameters (2/5,
40%). BG, heart rate, and QT interval represent the second most
used types of input parameters (1/5, 20%). According to GV
classification and detection algorithm, BG alone (3/6, 50%),
and BG and insulin (3/6, 50%) are equally ranked as the most
used types of input parameters, as shown in Figure 4.
Figure 4. Reported input features, machine learning class, and accuracy. ANN: artificial neural network; BBNN: block-based neural network; BG:
blood glucose; BNN: Bayesian Neural Network; DBN: deep belief network; DT: decision tree; ELM: extreme learning machine; GA: genetic algorithm;
GP: genetic programming; HMM: hidden Markov model; NAR: nonlinear autoregressive network; NARX: nonlinear autoregressive network with
exogenous inputs; NBC: Naive Bayes classifier; RNN: recurrent neural network; SVM: support vector machine; VTWNN: variable translation wavelet
neural network.
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Different kinds of data sources ranging from BG monitors,
physical activity, electrocardiogram (ECG), and heart rate
sensors have been used in the reviewed articles for
hyperglycemia, hypoglycemia, and GV classification and
detection algorithms. The reviewed articles relied on different
kinds of data formats including SMBG (finger sticks), CGM,
and ECG signals, as shown in Table 1. Generally, ECG signal
is the most used type of data format (51%), followed by CGM
(39%) and SMBG (10%). Specifically, hypoglycemia
classification and detection involve (CGM (n=11), ECG (n=24),
and SMBG (n=5)). Regarding, hyperglycemia classification
and detection (CGM (n=5) and ECG (n=1)) and GV
classification and detection (CGM (n=3)).
Table 1. Types of data formats used in the studies (N=49).
Count, n (%)Data type/format
19 (39)Continuous glucose monitoring
5 (10)Self-monitoring blood glucose
25 (51)Electrocardiogram signal
With regard to BG monitoring, different devices and brands
have been exploited for developing hypo-/hyperglycemia and
GV classification and detection algorithms, as shown in Table
2. Generally, Yellow Spring Instruments is the most used device
(50%) followed by Guardian Real Time (MinMed CGM; 28%).
GlycoMark (7%) is the third most used device followed by
HemoCue Glucose 201 (5%) and Self-Monitored BG (5%).
Specifically, the most used devices for hypoglycemia
classification and detection are Guardian Real Time (MinMed,
CGM; n=7), Yellow Spring Instruments (n=21), HemoCue
Glucose 201 (n=2), Dexcom CGM system (n=1), Self-Monitored
BG (SMBG; n=2), Medtronic Enlite CGM sensors (n=1),
Medtronic insulin pump (n=4), SensorWear armband (physical
activity; n=2), and Basis Peak fitness band (n=1). and Basis
Peak fitness band (n=1). As for hyperglycemia classification
and detection, Guardian Real Time (MinMed CGM; n=2) and
Medtronic insulin pump (n=3) had been used. With regard to
GV classification and detection, GlycoMark (n=3), Guardian
Real Time (MinMed CGM; n=3), and Medtronic insulin pump
(n=3) had been used.
Table 2. Types of devices used for the monitoring of blood glucose levels (N=42).
Count, n (%)Devices
12 (28)Guardian Real Time (MinMed, CGMa)
2 (5)HemoCue Glucose 201 (HemoCue)
21 (50)Yellow Spring Instruments
1 (3)Dexcom CGM system
1 (3)Medtronic Enlite CGM sensors
3 (7)GlycoMark
2 (5)Self-Monitored Blood Glucose-unknown device
aCGM: continuous glucose monitoring.
Various brands of physiological monitoring (heart rate and ECG
signals) devices have been exploited in the reviewed articles.
Generally, as shown in Table 3, Compumedics system is the
most used system (52%) followed by a customized device such
as a battery-powered chest belt–worn device (22%). HypoMon
is the third most used device (13%) followed by Basis Peak
fitness band (9%) and a self-designed portable apparatus (4%).
Specifically, for hypoglycemia classification and detection
purposes, various devices have been used such as HypoMon
(n=3), Basis Peak (n=2), Compumedics system (n=11), a
battery-powered chest belt–worn (n=5), and self-designed
portable apparatus (n=1). With regard to hyperglycemia
classification and detection, only 1 article has used the
Compumedics system (n=1), which indicates that heart rate and
ECG signals have a limited use in this case.
Table 3. Types of devices used for the monitoring of physiological parameters (heart rate and electrocardiogram signals; N=23).
Count, n (%)Devices
3 (13)HypoMon
2 (9)Basis peak fitness band
12 (52)Compumedics system
5 (22)A battery-powered chest belt–worn (customized)
1 (4)Self-designed portable apparatus (customized)
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Data preprocessing is an important stage of any machine
learning strategy. In this regard, there were various kinds of
data preprocessing strategies used in the reviewed articles. The
reviewed articles had relied on both BG and other physiological
(heart rate, ECG, skin impedance, and others) data, which of
course involves different preprocessing strategies depending
on the data type under consideration. Regarding the BG data,
various preprocessing approaches had been used including
differencing (derivative) BG values [27,28], CGM data
reconstruction, or smoothing using different methods such as
spline interpolation [29-33], a rough feature elimination, such
as fast separability and correlation analysis algorithm [28,29],
representing BG temporal change information [34], feature
selection and feature ranking [35], filtering using Pearson’s
correlation coefficient (PCC) and the t test, and the wrapper
approach using greedy backward elimination [33]. The other
physiological parameters (heart rate, ECG, skin impedance, and
others) had been preprocessed using different methods such as
normalization [36-38], feature extraction and selection [39,40],
feature extraction using fast Fourier transform (FFT) [41],
unsupervised restricted Boltzmann machine–based feature
representation [42], filtering techniques such as Infinite impulse
response high pass filter [41,43], correlation analysis [44-46],
and transformation of frequency domain into time domain (FFT)
[47].
Class of Machine Learning
Hypoglycemia Classification and Detection
Different classes of machine learning techniques have been
adopted in hypoglycemia prediction, classification, and detection
algorithms to predict, classify, and detect the incoming
hypoglycemia incident in people with type 1 diabetes, as shown
in Figure 4. Conventional feedforward ANN is the most adopted
class of machine learning, which is used in 26% (17/65) of the
studies , as shown in Multimedia Appendix 1. Hybridization of
machine learning techniques with other approaches such as time
series, fuzzy logic, and others are the second most adopted
approach (12/65, 18%). The SVM ranked the third most adopted
class of machine learning (9/65, 14%). DT ranked the fourth
most adopted technique (4/65, 6%). GA, time delay ANN and
time sensitive ANN, block-based neural network (BBNN), and
adaptive neural fuzzy inference system (ANFIS) are the fifth
most used classes of machine learning (3/65, 5%). Nonlinear
autoregressive network with exogenous inputs (NARX) and
nonlinear autoregressive network (NAR) along with Gaussian
process regression, combinational neural logic network , and
Bayesian neural network (BNN) ranked as the sixth most used
classes of machine learning (2/65, 3%). Deep belief network
(DBN), radial basis function neural network (RBFNN), and
variable translation wavelet neural network (VTWNN) are the
seventh most used classes of machine learning (1/65, 2%).
Hyperglycemia Classification and Detection
Hyperglycemia classification, prediction, and detection has been
practiced less when compared with hypoglycemia, which might
be linked because of its less severe short-term complications as
opposed to hypoglycemia incidences. However, irrespective of
this limitation, different types of machine learning techniques
have been adopted, as shown in Figure 4. For example, ANN
is the most used machine learning technique in 34% (3/9) of
the studies (feedforward (1/9) and feedback RNN (2/9)), as
shown in Multimedia Appendix 1 along with EA (3/9,34%)
(GA (1/9) and GP (2/9)). The HMM (2/9, 22%) is the third most
used followed by a hybrid approach (1/9, 11%).
Glycemic Variability Classification and Detection
GV detection is a recent development, which has great
importance in quantifying factors associated with
hypo-/hyperglycemia incidence. In this regard, there is some
research and development involving machine learning
techniques, as shown in Figure 4. For example, feedforward
ANN is the most used class of machine learning (3/8, 37%), as
shown in Multimedia Appendix 1. Naive Bayes classifier (NBC)
and SVM are the second most adopted techniques of machine
learning (2/8, 25%). DT is the third most used class of machine
learning (1/8, 13%).
Performance Metrics
The performance metrics used in the evaluation of
hypoglycemia, hyperglycemia, and GV classification and
detection algorithms are depicted in the outer ring, the middle
ring, and inner ring, respectively, as shown in Multimedia
Appendix 1. According to hypoglycemia classification and
detection, sensitivity, and specificity are the most used
performance metrics (37/58, 64%). Accuracy and precision are
the second most used performance metrics (9/58, 15%). Root
mean square error and mean square error are the third most used
performance metrics (4/58, 7%). Geometric mean is the fourth
most used performance metric (3/58, 5%). Correlation
coefficient is the fifth most used performance metric (2/58, 3%).
Time lag (TL), recall, and ROC curve are the sixth most used
performance metrics (1/58, 2%). According to hyperglycemia
classification and detection, accuracy and precision, root mean
square error and mean square error, time lag (TL), correlation
coefficient, recall, and false positive rate are the most used
performance metrics (2/15, 13%). ROC curve, geometric mean,
sensitivity, and specificity are the third most used performance
metrics (1/15, 7%). According to GV classification and
detection, accuracy, and precision are the most used performance
metrics (3/5, 60%). Sensitivity and specificity are the second
most used performance metrics (2/5, 40%).
Discussion
Principal Findings
The objective of this review was to identify, assess, and analyze
the state-of-the-art machine applications in BG pattern
classifications and anomaly detection: hyperglycemia,
hypoglycemia, and GV classification and detection. According
to the reviewed literature, the anomaly classification and
detection approach could be roughly categorized as either a
classifier-based or a model-based approach [19,21]. The
classifier-based approach mainly relies on using either a
specified threshold or some kinds of rules to classify the BG
levels as either normal or abnormal. The difference is that unlike
the model-based approach, the classifier-based approach requires
rigorous and deeper knowledge regarding the nature, size, and
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shape of the underlying anomalies under consideration so as to
develop the necessary threshold or rule to capture them.
However, the model-based approach only requires to demarcate
the boundary of what is known to be normal so as to capture
what is believed to be abnormal [21]. The model-based approach
does not require rigorous knowledge of the underlying expected
anomalies, that is, to fully understand and characterize the shape
and nature of the expected anomalies [22]. By simply defining
what is the expected normal pattern that the system should
exhibit, a model-based approach is capable of detecting
abnormal behavior, which is not considered as the normal
behavior of the system. Defining and discovering what is normal
is a challenging task especially for dynamic and complex
systems, for example, BG dynamics. However, this is often
tackled in a dynamic and complex system by either relying on
a machine learning model trained on large enough datasets or
using an explicit mathematical model of the system such as a
physiological or compartmental BG dynamics model [21].
Various classes of machine learning algorithms have been
adopted for the task. Regarding hypoglycemia classification
and detection, feedforward ANN, hybrid systems, SVM, DT,
GA, ANFIS, NARX, NAR, Gaussian process regression, DBN,
and BNN have been developed and tested. These techniques
have explored various kinds of input parameters notably BG,
heart rate, QT interval, insulin, diet, physical activity, galvanic
response, and skin impedance. Concerning hyperglycemia
classification and detection, RNN, GP, HMM, feedforward
ANN, GA, and hybrid systems have been developed and tested,
exploring various types of input parameters including BG,
insulin, heart rate, and QT interval. GV detection is a recent
development, which has great importance in quantifying factors
associated with hypoglycemia and hyperglycemia incidence. In
this regard, there is some research and development involving
machine learning techniques. For example, feedforward ANN,
NBC, SVM, and DT have been tested up to the task using BG
and insulin delivery profiles.
Generally, all of the studies have relied on either indirect
indicator variables such as heart rate, QT interval, and others
or a subset of input parameters that affects BG dynamics. The
patient’s contextual information, for example, meals, physical
activity, insulin, and sleep, have a significant effect on BG
dynamics, and a proper anomaly classification and detection
algorithm should consider the effects of these parameters. In
this regard, however, the individual patient is expected to record
meal, insulin, and physical activity data. One of the main
limitations is meal modeling, where most of the algorithm
depends on the individual estimation of carbohydrate, which is
prone to errors and further aggravates the degradation to
detection performance. With regard to physical activity, there
are various wearables and sensors that can record the
individual’s physical activity load and durations. However, there
is the lack of a uniform approach among the studies with certain
limitations on the way these signals are employed in the
classification and detection algorithms. For example, there are
some studies that consider levels of activity as low, moderate,
and high and others consider descriptive features by
summarizing the number, intensity, steps, exercise durations,
and others to better quantify the effect of physical activities.
Moreover, recording insulin dosage has its inherent limitations,
which might affect the detection performance. For example,
blockage of insulin flow from the insulin pump because of the
infusion set failure and error incurred during manual
registrations might pose a significant challenge in the
performance of the detection system. Furthermore, CGM is
becoming one of the most important components in these
classification and detection algorithms. However, even if CGM
advancement has enabled patients to have continuous estimation
of their subcutaneous glucose levels, it has limitations when
used in a personalized detection system (an alarm). In this
regard, recent studies have showed that autocorrelation of the
CGM reading vanishes after 30 min, making the detection
performance to degrade afterward. These findings suggest that
any classification and detection algorithms aiming for a better
lead time should consider other patient’s contextual information
and various features of the CGM itself. There are some studies
that develop a model by assessing several features of the CGM
signal so as to compensate for its inaccuracy. Moreover, CGM
is found to be inaccurate during hypoglycemia episodes, that
is, insulin-induced hypoglycemia versus spontaneous
hypoglycemia. In this regard, insulin-induced hypoglycemia is
found to be difficult to detect as compared with spontaneous
hypoglycemia. Fast occurring hypoglycemia is difficult to detect
because of the blood-interstitial delay, which makes them
important features to be detected by a given model. Furthermore,
CGM calibration frequency and timing also affects the
performance of the classification and detection algorithm.
The reviewed studies are limited to and could be roughly
categorized by age groups (children, young, adult, and old),
time of the day (diurnal vs nocturnal) and configurations (online
vs offline). For example, most of the studies consider nocturnal
hypoglycemia detection, considering the fact that most of
hypoglycemia crises occurred during nighttime and also the
crises during this time have a bad consequence as compared
with the diurnal period. Moreover, it is a fact that nocturnal
detection is simpler as compared with the diurnal considering
the dynamics of the patients. However, irrespective of these
challenges, there are also studies that consider the diurnal period.
However, there are limited studies that attempt to develop an
algorithm that could detect anomalies in both of those contexts.
With regard to the age group, most surveys reported that age
group has a great effect on BG dynamics, which is typically
related with the dynamics and active lifestyle adopted by each
group. Therefore, it is deemed a necessary approach to consider
a personalized algorithm for each age group. With regard to the
configuration, there are fewer attempts of online (real-time)
algorithms, where almost all of the algorithms were tested and
implemented in the offline mode. In this regard, the most crucial
issues concerning machine learning strategies could be the
necessity of frequent retraining when subjected to a real-time
and dynamic task.
In addition, the most important component in classification and
detection algorithms is the threshold used to differentiate the
normal from the abnormal. In this regard, almost most of the
studies have used a static threshold based on suggestions either
from the literature or physicians and other concerned bodies
such as the American Diabetes Association. However, the
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critical issues in this approach are that the threshold might vary
from patient to patient and also some patients might not feel
any symptoms at the specified threshold (when using indirect
indicators such as heart rate, QT interval, and others). However,
there are some studies that employed a fuzzy logic–based
approach by having a continuous decision space.
In principle, any future BG anomaly classification and detection
algorithm should be expected to detect any upcoming anomalies
as soon as possible (lead time—giving more response time),
avoid any false alarm at any cost, perform in real-time (in an
online fashion), adapt with the dynamics of BG evolution (learn
continuously), automatically tune its parameters without user
intervention, be able to perform throughout the day in a free
living condition (diurnal and nocturnal periods), and incorporate
as many input variables to better capture the dynamics. In this
regard, for example, the most crucial issues concerning a
real-time (online) machine learning algorithm could be the
necessity of frequent retraining when subject to a real-time and
dynamic task. Moreover, developing a model that considers a
real-time and adaption-to-free-living condition needs to
incorporate a wide range of parameters that affect BG dynamics.
Furthermore, it should properly consider and address the
inherent technological limitation that affects the performance
of the detection algorithm. Almost all of the studies need a
proper clinical validation to be integrated into a smartphone and
CGM for a real-time application. This can be better described
by looking at the number of samples used and their validation
strategies (see Multimedia Appendix 2). Therefore, future
studies should give more emphasis on clinical validation by
taking a sufficient number of subjects in the development and
testing phase so as to better quantify the inter- and
intravariability among patients. In addition, the most crucial
concept of justifying and reporting the underlying cause, as
because of either patient controllable or patient uncontrollable
parameters, for the detected anomalies is not addressed in any
of the reviewed literature. For example, the underlying cause
of hyperglycemia incidences could be patient controllable
parameters such as diet or patient uncontrollable parameters
such as stress and infections. Therefore, in this regard, a proper
hyperglycemia classification and detection system might be
expected to be able to identify and report the underlying cause,
which has a greater significance to the patient especially during
infection crises.
Summary of Existing Efforts: Machine Learning
Techniques
Artificial Neural Network
There are various types of ANNs used in solving BG
classification and anomaly detection tasks: hypoglycemia,
hyperglycemia, and GV classification and detection. Regarding
hypoglycemia classification and detection, for instance, Eljil et
al [48], had proposed a special type of ANN known as the
time-sensitive ANN and compared the result with a time delay
neural network, NARX, distributed time delay neural network,
and NAR. San et al [37,49] proposed an evolvable BBNN and
compared the result with feedforward ANNs and multiple
regression. Moreover, San et al [42] proposed a DBN and
compared the result with a wavelet neural network, a
feedforward ANN, and multiple regression models. Some of
the studies have also investigated the advantage of having a
separate feature extraction and classification unit. In this regard,
for example, both Laione et al [47] and Nguyen et al [41,50]
have proposed an ANN using FFT for data extraction. Nguyen
et al [41] have further trained the network through a 2-step
process that combines the advantage of GA and the Levenberg
Marquardt algorithm. Chan et al and Yan et al [51,52] also
proposed a neural network–based rule discovery system that
consisted of a neural network–based classification unit and
rule-based extraction unit. There are some studies that optimized
the ANN parameters through a particle swarm optimization
technique. For example, Ling et al [53], Phyo et al [36,54,55],
and San et al [56] proposed a new hybrid rough neural network,
a VTWNN, a normalized RBFNN, and a combinational neural
logic network with the neural logic AND, OR, and NOT gates,
respectively, where the design parameters of the network were
optimized through a hybrid particle swarm optimization with
wavelet mutation operation. Moreover, Nguyen et al [43,57]
also proposed an ANN that is optimized through a standard
particle swarm optimization strategy. Furthermore, some studies
have investigated extreme learning machines (ELMs). For
instance, Ling et al [58] and San et al [59] proposed a
feedforward ANN trained through an ELM and compared the
result with a feedforward ANN optimized through particle
swarm optimization, multiple regression–based fuzzy inference
system, fuzzy inference system, and linear multiple regression.
Mo et al [60] have also used ELMs and regularized the ELMs
on CGM data. In addition, Nguyen et al [61-63] and Ngo et al
[64] had proposed an optimal BNN algorithm using feedforward
ANN architecture. There are some studies that tried to integrate
a physiological model with ANN. For instance, Bertachi et al
[65] integrated the physiological model of an individual diabetes
patient with an ANN to predict nocturnal hypoglycemia events.
Regarding, hyperglycemia classification and detection, there is
only 1 study by Nguyen et al [38] that uses a feedforward
multilayer ANN trained using different training algorithms, that
is, gradient descent, gradient descent with momentum, scaled
conjugate gradient, and resilient back propagation. Regarding
GV classification and detection, the reviewed studies had been
performed either for detection purposes or for automated metrics
purposes. For the detection purpose, for example, Wiley et al
[33] proposed Naive Bayes (NB), multilayer perceptron (MLP)
ANN, and SVM models to detect excessive GV on CGM data
and compared the accuracy of the result with the other 2 diabetes
experts. Concerning the automated metrics, Marling et al [66]
had developed an NBC (probabilistic reasoning), an MLP ANN,
and a logistic model tree (DT built using logistic regression),
which could be used to monitor CGM data. Moreover, Marling
et al [32] also proposed an MLP ANN and support vector
regression to develop a consensus perceived GV metric.
Support Vector Machines, Kernel Function, and
Gaussian Process Regression
SVM, kernel function (KF), and Gaussian process regression
have been exploited for hypoglycemia classification and
detection purposes in the reviewed literature. For example,
Georga et al [67] developed a support vector regression for
hypoglycemia prediction and compared the performance with
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a feedforward MLP ANN and Gaussian process regression.
Georga et al [68] also proposed support vector regression and
Gaussian process regression for BG prediction so as to indicate
the daily incidences of hyperglycemia and hypoglycemia to the
patients as well as provision of decision support to physicians
in making the decision about treatment and risk of
complications. Moreover, Jensen et al [29,30] developed an
automatic pattern recognition system so as to detect
hypoglycemia incidences retrospectively using CGM data and
thereby to foster a thorough evaluation of past events and
discussion with their caregivers. Jensen et al [28,69] also
proposed a real-time pattern classification model by using
several features from the CGM data so as to detect hypoglycemia
incidences in real-time. Furthermore, Marling et al [70] proposed
a hypoglycemia detection algorithm that incorporates
noninvasive sensor data from fitness bands and also compared
different kernels for the task: linear, Gaussian, and quadratic
kernels. Nuryani et al [71] also proposed a swarm-based SVM
algorithm using the repolarization variabilities as input so as to
detect hypoglycemia incidences.
Genetic Programming and Genetic Algorithm
There is little visibility of GP and GA usage in their nonhybrid
form for BG classification and anomaly detection tasks:
hypoglycemia, hyperglycemia, and GV classification and
detection. However, there are some studies that use these
techniques in their hybrid form. For example, Ling et al
[44,72,73] developed a hypoglycemia detection algorithm using
a GA-based multiple regression coupled with a fuzzy inference
system. The study exploited the GA so as to optimize the fuzzy
rules, membership function of the fuzzy inference system, and
also model parameters of the regression.
Random Forest
RF and DT have been mostly used in the context of
hypoglycemia classification and detection tasks. For example,
Eljil et al [27] proposed DTs using different techniques, namely,
C4.5, J4.8, REPTree, bagging, and the cost-sensitive version of
J4.8. Jung et al [74] also proposed DTs using new predictor
variables using CGM data. Moreover, Jung et al [34] proposed
a DT- and SVM-based prediction model using self-monitored
BG. Zhang et al [35] also proposed a new approach using the
classification tree to predict the occurrences of acute
hypoglycemia during intravenous insulin infusion before the
actual hypoglycemic events take place.
Hidden Markov Model
Generally, HMM is used to model an environment that could
better describe the evolution of the individual BG dynamics. In
this regard, there are some studies that use HMM to develop
model-based BG anomaly classification and detection
algorithms. For example, Zhu et al [15,75] studied an approach
for automatic detection of anomalies in individual BG data,
using a model trained with historical data containing daily
normal measurements. The trained Markovian world tries to
analyze the incoming BG data and flags if it deviates from what
is known by the model.
Hybrid and Ensemble Models
Hybridization approaches have been extensively used when
looking for performance improvement by exploiting the
advantage from 2 or more different approaches [16]. In this
regard, there are some attempts in the reviewed articles which
tried merging different approaches for enhanced performance
in hypoglycemia classification and detection. For example,
hybridization of an ANN with other techniques is demonstrated
in some of these studies. Chan et al [76] developed a hybrid
system that consisted of an ANN and a GA and also compared
the performance with MLP ANN and classical statistical
algorithms. Ghevondian et al [77] proposed a novel hybrid
system of a fuzzy neural network ANN estimator to predict the
BG profile and hypoglycemia incidences. San et al [78] proposed
a hybrid system using an ANFIS and compared the performance
with the wavelet neural network, feedforward ANN, and
multiple regression. There is also some literature that tries to
hybridize the SVM with other techniques. For example, Nuryani
et al [39,79] proposed a hybrid fuzzy SVM and investigated the
applicability of 3 KFs: radial basis, exponential radial basis,
and polynomial function for the task. Moreover, Nuryani et al
[40,80] also further developed a novel strategy using a hybrid
particle swarm-based fuzzy SVM technique. Fuzzy reasoning
models are also tested in some of the studies. For example, Ling
et al [81] developed a hybrid particle swarm-optimization–based
fuzzy reasoning model, where the fuzzy rules and the
fuzzy-membership functions are optimized through a hybrid
particle swarm optimization with wavelet mutation. The model
is also compared with feedforward ANN and multiple-regression
models. Mathews et al [46] developed a hybrid model using a
fuzzy inference system with multiple regression, where the
fuzzy rules are optimized through a GA. The study also
compares the performance of the developed system with an
ANN whose parameters are optimized through particle swarm
optimization. In addition, San et al [82] proposed a hybrid
system based on rough sets concepts and neural computing. The
study has compared various hybrid approaches trained through
hybrid particle swarm optimization with wavelet mutation
including the rough BBNN, BBNN, rough feedforward ANN,
wavelet neural network, SVM with an RBF, and conventional
feedforward ANN. Ling et al [45] also proposed an alarm system
based on the hybrid neural logic network with multiple
regression. Lai et al [83] developed a fuzzy inference system
for hypoglycemia detection, where the system parameters are
optimized through an intelligent optimizer.
Owing to the complexity of BG dynamics, it remains difficult
to achieve an accurate result in every circumstance. One model
can have better accuracy in some circumstances and the other
model can achieve better accuracy where the first model fails
to achieve a comparable result. Therefore, it is natural to look
for possibilities to exploit the strengths from these different
models to achieve better accuracy in most of the circumstances,
which lead to ensemble approaches [16]. An ensemble approach
is generally favored when one is interested to merge 2 or more
different models for improved performance. In this regard, there
are some studies that try to combine 2 different models looking
for performance improvement in the overall system. In this
regard, Daskalaki et al [84] proposed an early warning system,
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for both hyperglycemia and hypoglycemia, using RNN and AR
with output correction module models. Moreover, the study
investigated the performance improvement from the combined
use of both RNN and AR with an output correction module.
Moreover, Botwey et al [31] proposed combining an AR model
with output correction and an RNN based on different data
fusion schemes including the Dempster-Shafer evidential theory,
GAs, and GP.
Conclusions
Despite the complexity of BG dynamics, there are many attempts
to capture hypoglycemia and hyperglycemia incidences and the
extent of an individual GV using different approaches. Recently,
because of the ubiquitous nature of self-management mHealth
apps, sensors and wearables have paved the way for the
continuous accumulation of self-collected health data, which in
turn contributed for the widespread research of machine learning
applications in these tasks. In the reviewed articles, generally,
the anomaly classification and detection approaches could be
categorized as either model (process)–based or classifier
(rule)–based approaches. Hypoglycemia classification and
detection has been given more attention than hyperglycemia
and GV detection, which might be because of its serious
complication and the comparable complexity involved. The
state-of-the-art indicates that various classes of machine learning
have been developed and tested in these tasks. Regarding
hypoglycemia classification and detection, feedforward ANNs,
hybrid systems, SVM, DT, GA, adaptive neural fuzzy inference
system, NARX, and NAR, Gaussian process regression, DBN,
and BNN have been developed and tested. These techniques
have explored various kinds of input parameters, notably BG,
heart rate, QT interval, insulin, diet, physical activity, galvanic
response, and skin impedance. Concerning hyperglycemia
classification and detection, RNN, GP, HMM, feedforward
ANN, GA, and hybrid systems have been developed and tested,
exploring various types of input parameters including BG,
insulin, heart rate, and QT interval. GV detection is a recent
development, which has great importance in quantifying factors
associated with hypoglycemia and hyperglycemia incidence. In
this regard, there is some research and development involving
machine learning techniques, for example, the feedforward
ANN, NBC, and SVM.
Most of these studies have used a theoretical threshold suggested
either by the literature or physicians and various concerned
bodies such as the American Diabetes Association. However,
the problem here is that some patients might feel no symptoms
at the specified threshold, and it may vary from patient to
patient. Therefore, a model should consider such differences
among the patients (intra- and intervariability) and also track
its temporal change over time. Moreover, the studies should
give more emphasis on the TL and various types of inputs used.
Furthermore, researchers should give proper emphasis to develop
anomaly classification and detection models, which are capable
of justifying and reporting the underlying cause, as either due
to patient controllable or patient uncontrollable parameters.
Generally, we foresee that these developments might encourage
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Analysis of reported parameters, data characteristics, class of machine learning, and performance metrics.
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Multimedia Appendix 2
Detail on reported accuracy, inputs and performance metrics used, and machine learning categorization.
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ANFIS: adaptive neural fuzzy inference system
ANN: artificial neural network
AR: autoregressive
BBNN: block-based neural network
BG: blood glucose
BNN: Bayesian Neural Network
CGM: continuous glucose monitoring.








HMM: hidden Markov model
MLP: multilayer perceptron
NAR: nonlinear autoregressive network
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